Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
m-ceNK cells
/
ImmunityBio
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
m-ceNK cells
/
ImmunityBio
Enrollment change, Trial completion date, Trial primary completion date, Metastases:
QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov) - Jun 18, 2023
P1
, N=50, Recruiting,
Sponsor: ImmunityBio, Inc.
N=30 --> 50 | Trial completion date: Jun 2022 --> Dec 2024 | Trial primary completion date: Jun 2022 --> Jun 2024
||
||||||||
m-ceNK cells
/
ImmunityBio
Enrollment open, Metastases:
QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov) - Jul 26, 2021
P1
, N=30, Recruiting,
Sponsor: ImmunityBio, Inc.
N=30 --> 50 | Trial completion date: Jun 2022 --> Dec 2024 | Trial primary completion date: Jun 2022 --> Jun 2024 Not yet recruiting --> Recruiting
||
||||||||
m-ceNK cells
/
ImmunityBio
New P1 trial, Metastases:
QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov) - May 24, 2021
P1
, N=30, Not yet recruiting,
Sponsor: ImmunityBio, Inc.